Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
Demos of the Archer™ Shoulder Systems will be available at the 2021 Ortho Summit and the 2021 ASES Annual Meeting
NAPLES, Fla., Dec. 13, 2021 – Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, will provide demonstrations of its innovative Archer™ Shoulder Systems at two major upcoming events: the Orthopaedic Summit 2021, Dec. 11-14 in Las Vegas, Nev. and the 2021 American Shoulder & Elbow Surgeons (ASES) Annual Meeting, Dec. 15-17 in Tampa, Fla.
The Archer CSR Total Shoulder System will be featured in presentations at both events:
Attendees can learn more and talk with the Catalyst OrthoScience team at booth #116 at the Ortho Summit and booth #7 at the ASES Annual Meeting or go to www.CatalystOrtho.com.
About Catalyst OrthoScience Inc.
Catalyst OrthoScience is disrupting the usual approaches to shoulder replacement surgery.
Founded in 2014 by orthopedic surgeon Steven Goldberg, M.D., the company’s goal is to develop innovative medical solutions that make orthopedic surgery less invasive and more efficient for both surgeons and patients. The company has a growing portfolio of patents and pending patents on its distinctive surgical offerings. Headquartered in Naples, Fla., Catalyst products are available across the U.S. For more information, visit www.CatalystOrtho.com.
###
Nice to meet you. We use cookies to ensure that we give you the best experience on our website.
Sounds Good